BioSpace News Archive

- Laborie Medical Technologies Inc. signed a definitive agreement today and entered into a multi-faceted, strategic partnership with Urotronic Inc. (Urotronic), a Minnesota-based medical device company currently conducting clinical trials to support regulatory approval of Optilume™,

Leon Medical Centers Health Plans, a Cigna company, announced it has achieved Five out of Five Stars for quality and performance from the Centers for Medicare & Medicaid Services for 2021.

The U.S. Food and Drug Administration’s mission to protect and promote public health by ensuring the safety of the nation’s food supply, as well as the safety and efficacy of medical products, has always relied on a rigorous analysi

Elusys Therapeutics, Inc. (Elusys) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending marketing authorization under exceptional circumstances for Obiltoxaximab SFL (obiltoxaximab),

Athersys, Inc. will release its third quarter 2020 financial results at approximately 4:00 PM Eastern Time on Monday, November 9, 2020, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.

Today, the U.S. Food and Drug Administration announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years. These trial research grants, awarded through the Congressionally-funded Orphan Products Grants Program , en

Data reported through AAOS Registries now qualifies for new Alternate Quality Measures Set

The evidence-based app for stress and anxiety will be widely available to support mental wellness during COVID-19 crisis and beyond [08-October-2020] NEW YORK , Oct. 8, 2020 /PRNewswire/ -- Wise Therapeutics , a digital therapeutics company created to improve access to effective mental health treatments using digital interventions, announced the closing of its firs

Today, Amber Specialty Pharmacy announces that it will begin dispensing EMFLAZA® (deflazacort) to patients throughout the United States.

Abiomed, Inc . (NASDAQ: ABMD) announced that on Thursday, October 29, 2020, the Company will release financial results for the second quarter of fiscal 2021. The Company will host a conference call to discuss the results on Thursday, October 29, 2020 at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Todd Trapp, Chief Financial Officer, will host the conference call. To listen to